Skip to main content
JBS logo

JBS · Jbs N.V. · Documents

Track JBS — free
$12.16 +0.26 (+2.18%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Market Cap
$40.00B
Shares
3.29B
Volume · Nov 13 9.4M Avg daily vol (3M) 6.26M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $86.18B up 11.7% 20-F filed Mar 25, 2026 Quarterly report New FY2026 Q3 Revenue $22.74B up 0.6% 10-Q filed Nov 9, 2026 Latest results New EBITDA falls 36% as net leverage rises to 3.54x 8-K filed Nov 9, 2026 Earnings call Q2 2026 earnings call Held Aug 12, 2026
2026
Nov 9
Current report 8-K
Flora and Canal Rural Acquisitions Announced

JBS announced agreements to acquire Flora for R$2.968 billion and Canal Rural for R$88.1 million; both transactions are expected to close in December 2026, subject to customary closing conditions.

Unregistered sale of equity, Regulation FD disclosure, Other events
4 source passages
JBS N.V. (“JBS”) (NYSE: JBS; B3: JBSS32) announced today the acquisition of 100% of Flora, a Brazilian consumer products company owned by J&F Group, JBS’s controlling shareholder, in a transaction valued at US$542 million. JBS S.A. has agreed to acquire Flora for R$2.968 billion, subject to certain adjustments (the “Flora Purchase Price”). JBS S.A. has agreed to acquire Canal Rural for R$88.1 million, subject to certain adjustments (the “Canal Rural Purchase Price”). The Transactions are expected to close in December 2026, subject to customary closing conditions, unless otherwise agreed by the parties. Open the document at this passage
Nov 9
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises as profit and EBITDA fall

JBS N.V. reported nine-month net revenue of US$68.2 billion, but net income fell to US$334.3 million and Adjusted EBITDA to US$3.7 billion.

Revenue $22.74B ▲ 0.6% Net income $164.43M ▼ 71.7% Diluted EPS $0.15 ▼ 71.2%
Read from the MD&A section
3 source passages
Our net revenue was US$68.2 billion and US$63.1 billion for the nine-month periods ended September 30, 2026 and 2025, respectively. We recorded a net income of US$334.3 million and US$1.8 billion for the nine-month periods ended September 30, 2026 and 2025, respectively. Our Adjusted EBITDA was US$3.7 billion and US$5.1 billion for the nine-month periods ended September 30, 2026 and 2025, respectively. Open the document at this passage
Nov 9
Current report 8-K
EBITDA falls 36% as net leverage rises to 3.54x

JBS N.V. reported 3Q26 net sales of $22.7 billion, up 1% from prior year, while IFRS adjusted EBITDA fell 36% to $1,181 million and EPS was $0.15. Net leverage rose to 3.54x, and free cash flow was negative US$167 million.

Financial results
6 source passages
JBS N.V. (NYSE: JBS; B3: JBSS32), announces today its 3Q26 results. •Net Sales of $22.7 billion, up 1% from prior year •IFRS Adjusted EBITDA of $1,181 million, down 36% from prior year •EPS of $0.15, vs. $0.52 from prior year Free cash flow was negative US$167 million in 3Q26, with a US$551 million decrease year-over-year, explained by (i) a US$653 million decline in Adjusted EBITDA and (ii) higher working capital consumption in Brazil, particularly inventories. Net leverage ended the quarter at 3.54x. Open the document at this passage
Oct 16
Registration statement F-4
Registration statement

JBS N.V. is offering to exchange US$1,500,000,000 of 5.625% Senior Notes due 2037 and US$1,000,000,000 of 6.400% Senior Notes due 2057 for registered notes of the same series, originally issued on April 13, 2026.

Read from the first part of this long document
Sep 15
Current report 8-K
Other events AI summary on its way
Aug 10
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $23.9B ▲ 13.8% Net loss $102.11M Diluted EPS -$0.09
Mar 25
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $86.18B ▲ 11.7% Net income $2.02B ▲ 14.6% Diluted EPS $1.89 ▲ 14.5%
2025
Showing 1–50 of 69 documents
Key facts CIK 1791942 CUSIP N4732M103 13F (30d) 235 filings 225 filers Visit website Investor relations